DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Van Mieghem NM, Unverdorben M, Hengstenberg C. et al; ENVISAGE-TAVI AF Investigators.
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR.
N Engl J Med 2021;
385 (23) 2150-2160
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.